HRTX
Price
$2.14
Change
-$0.09 (-4.04%)
Updated
Apr 3 closing price
Capitalization
339.69M
38 days until earnings call
RNAC
Price
$12.34
Change
-$0.61 (-4.71%)
Updated
Apr 3 closing price
Capitalization
319.69M
Ad is loading...

HRTX vs RNAC

Header iconHRTX vs RNAC Comparison
Open Charts HRTX vs RNACBanner chart's image
Heron Therapeutics
Price$2.14
Change-$0.09 (-4.04%)
Volume$1.02M
Capitalization339.69M
Cartesian Therapeutics
Price$12.34
Change-$0.61 (-4.71%)
Volume$83.67K
Capitalization319.69M
HRTX vs RNAC Comparison Chart
Loading...
HRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HRTX vs. RNAC commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRTX is a Hold and RNAC is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (HRTX: $2.14 vs. RNAC: $12.34)
Brand notoriety: HRTX and RNAC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HRTX: 57% vs. RNAC: 103%
Market capitalization -- HRTX: $339.69M vs. RNAC: $319.69M
HRTX [@Biotechnology] is valued at $339.69M. RNAC’s [@Biotechnology] market capitalization is $319.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HRTX’s FA Score shows that 0 FA rating(s) are green whileRNAC’s FA Score has 0 green FA rating(s).

  • HRTX’s FA Score: 0 green, 5 red.
  • RNAC’s FA Score: 0 green, 5 red.
According to our system of comparison, RNAC is a better buy in the long-term than HRTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HRTX’s TA Score shows that 4 TA indicator(s) are bullish while RNAC’s TA Score has 4 bullish TA indicator(s).

  • HRTX’s TA Score: 4 bullish, 4 bearish.
  • RNAC’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both HRTX and RNAC are a good buy in the short-term.

Price Growth

HRTX (@Biotechnology) experienced а -7.36% price change this week, while RNAC (@Biotechnology) price change was -14.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

Reported Earning Dates

HRTX is expected to report earnings on May 12, 2025.

RNAC is expected to report earnings on Aug 08, 2024.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HRTX($340M) has a higher market cap than RNAC($320M). HRTX YTD gains are higher at: 39.869 vs. RNAC (-31.100). HRTX has higher annual earnings (EBITDA): -5.06M vs. RNAC (-75.99M). RNAC has more cash in the bank: 213M vs. HRTX (59.3M). RNAC has less debt than HRTX: RNAC (14M) vs HRTX (178M). HRTX has higher revenues than RNAC: HRTX (144M) vs RNAC (38.9M).
HRTXRNACHRTX / RNAC
Capitalization340M320M106%
EBITDA-5.06M-75.99M7%
Gain YTD39.869-31.100-128%
P/E RatioN/AN/A-
Revenue144M38.9M370%
Total Cash59.3M213M28%
Total Debt178M14M1,271%
FUNDAMENTALS RATINGS
HRTX vs RNAC: Fundamental Ratings
HRTX
RNAC
OUTLOOK RATING
1..100
6463
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
99
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4489
P/E GROWTH RATING
1..100
10034
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HRTX's Valuation (70) in the Biotechnology industry is in the same range as RNAC (99). This means that HRTX’s stock grew similarly to RNAC’s over the last 12 months.

HRTX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RNAC (100). This means that HRTX’s stock grew similarly to RNAC’s over the last 12 months.

HRTX's SMR Rating (100) in the Biotechnology industry is in the same range as RNAC (100). This means that HRTX’s stock grew similarly to RNAC’s over the last 12 months.

HRTX's Price Growth Rating (44) in the Biotechnology industry is somewhat better than the same rating for RNAC (89). This means that HRTX’s stock grew somewhat faster than RNAC’s over the last 12 months.

RNAC's P/E Growth Rating (34) in the Biotechnology industry is significantly better than the same rating for HRTX (100). This means that RNAC’s stock grew significantly faster than HRTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HRTXRNAC
RSI
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
79%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 18 days ago
84%
Bullish Trend 15 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Ad is loading...
HRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PNRAX50.24N/A
N/A
Putnam Research A
TISCX25.74N/A
N/A
Nuveen Large Cap Responsible Eq R6
RYVPX7.13N/A
N/A
Royce Smaller-Companies Growth Svc
FSTRX31.77N/A
N/A
Federated Hermes MDT Large Cap Value A
BGGKX24.82N/A
N/A
Baillie Gifford US Equity Growth K

HRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRTX has been loosely correlated with GSGTF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if HRTX jumps, then GSGTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRTX
1D Price
Change %
HRTX100%
-4.04%
GSGTF - HRTX
45%
Loosely correlated
N/A
AMRN - HRTX
44%
Loosely correlated
-2.18%
ACAD - HRTX
42%
Loosely correlated
-3.01%
ABOS - HRTX
39%
Loosely correlated
-8.52%
SYRE - HRTX
38%
Loosely correlated
-9.68%
More

RNAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNAC has been closely correlated with SNPX. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if RNAC jumps, then SNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNAC
1D Price
Change %
RNAC100%
-4.71%
SNPX - RNAC
91%
Closely correlated
-4.22%
ALLR - RNAC
86%
Closely correlated
-7.03%
NRXP - RNAC
86%
Closely correlated
-6.97%
PALI - RNAC
81%
Closely correlated
-3.54%
HRTX - RNAC
37%
Loosely correlated
-4.04%
More